Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Rakesh Jhunjunwala led consortium to acquire Star Health for Rs 6500 crore : Report

      Rakesh Jhunjunwala led consortium to acquire Star Health for Rs 6500 crore : Report

      Ruby Khatun Khatun20 Aug 2018 5:54 PM IST
      Mumbai: Ace investor Rakesh Jhunjunwala led consortium has agreed to acquire Star Health and Allied Insurance valuing the company at Rs 6,500 crore,...
      Illegal internet drugs pharmacy busted in Delhi, 4 held

      Illegal internet drugs pharmacy busted in Delhi, 4 held

      Ruby Khatun Khatun20 Aug 2018 10:45 AM IST
      New Delhi: An illegal internet pharmacy, allegedly shipping drugs to overseas locations like the US and Canada, based in Delhi has been busted by the...
      Jubilant Life Sciences plans Rs 550 crore capex in FY19

      Jubilant Life Sciences plans Rs 550 crore capex in FY19

      Ruby Khatun Khatun20 Aug 2018 10:30 AM IST
      MUMBAI: Pharma company Jubilant Life Sciences has earmarked Rs 550 crore for capital expenditure (capex) in the current financial year, a top company...
      Delhi official wins WHO award on tobacco control initiative

      Delhi official wins WHO award on tobacco control initiative

      Ruby Khatun Khatun20 Aug 2018 10:15 AM IST
      New Delhi: Delhi government's additional director of health S K Arora has been awarded the prestigious WHO World No Tobacco Day 2018 Award for his...
      FDA approves Bristol-Myers Opdivo for small cell lung cancer

      FDA approves Bristol-Myers Opdivo for small cell lung cancer

      Ruby Khatun Khatun20 Aug 2018 10:00 AM IST
      Bristol-Myers Squibb Co said the U.S. Food and Drug Administration approved its treatment, Opdivo, for patients whose lung cancer had progressed even...
      OxyContin maker Purdue taps financial restructuring adviser - sources

      OxyContin maker Purdue taps financial restructuring adviser - sources

      Ruby Khatun Khatun20 Aug 2018 9:45 AM IST
      NEW YORK/BOSTON: OxyContin maker Purdue Pharma LP has tapped law firm Davis Polk & Wardwell LLP for financial restructuring advice, as its...
      Trump pushes US lawsuit against drug companies over opioids

      Trump pushes US lawsuit against drug companies over opioids

      Ruby Khatun Khatun20 Aug 2018 9:30 AM IST
      WASHINGTON: U.S. President Donald Trump on Thursday again pressed U.S. Attorney General Jeff Sessions to sue drug companies over the nation’s ongoing...
      Jaslok Hospital looks to handover its daily operations; Hospital Giants line up

      Jaslok Hospital looks to handover its daily operations; Hospital Giants line up

      Ruby Khatun Khatun19 Aug 2018 12:39 PM IST
      Hospital giants Radiant Life Care, Malaysia's IHH Healthcare, Zydus Hospitals, and the Hinduja Group are considering a proposal to run daily...
      AYUSH ministry introduces scheme for monitoring drugs safety aspects

      AYUSH ministry introduces scheme for monitoring drugs safety aspects

      Ruby Khatun Khatun19 Aug 2018 10:30 AM IST
      New Delhi: The AYUSH Ministry introduced a new central sector scheme for monitoring of the safety aspects of Ayurveda, Siddha, Unani and Homoeopathy...
      Microsoft, Apollo Hospitals unveil AI to predict cardiovascular disease risk score

      Microsoft, Apollo Hospitals unveil AI to predict cardiovascular disease risk score

      Ruby Khatun Khatun19 Aug 2018 10:15 AM IST
      New Delhi: Microsoft India and Apollo Hospitals have partnered to build an artificial intelligence-powered platform, designed to predict the risk of...
      Eisai sets price tag of about 17,000 dollar on liver cancer drug

      Eisai sets price tag of about 17,000 dollar on liver cancer drug

      Ruby Khatun Khatun19 Aug 2018 10:00 AM IST
      Japan’s Eisai Co Ltd said it would price its cancer drug Lenvima at about $17,000 for a month’s supply before discounts after the U.S. Food and Drug...
      Mylan launches first generic for Adcirca tablets

      Mylan launches first generic for Adcirca tablets

      Ruby Khatun Khatun19 Aug 2018 9:45 AM IST
      HERTFORDSHIRE, England, and PITTSBURGH: Global pharmaceutical company Mylan N.V. announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok